Charles Greg Guyer - 28 Apr 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
28 Apr 2023
Net transactions value
-$394,642
Form type
4
Filing time
08 May 2023, 16:20:57 UTC
Previous filing
17 Mar 2023
Next filing
10 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $15,984 +239 +0.48% $66.88 49,703 28 Apr 2023 Direct F1
transaction BMRN Common Stock Tax liability $410,626 -4,302 -8.7% $95.45 45,401 04 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.